Grants for For profit organizations other than small businesses - Science and Technology

This grant provides financial assistance to local governments and authorities in Minnesota for investigating and cleaning up contaminated sites to promote redevelopment and increase property tax revenue.

This funding opportunity supports innovative projects that develop advanced high-voltage direct current technologies to enhance the resilience and sustainability of the U.S. energy grid, targeting domestic entities and collaborations focused on improving power transmission systems.

The City of Wentzville's Facade Improvement Grant Program aims to preserve historic structures and prevent neighborhood deterioration through renovation and restoration efforts. This initiative is a 50-50 matching grant, with individual projects eligible for up to $10,000. While the description does not explicitly state a foundation mission, the program's focus on historic preservation and community revitalization aligns with broader municipal goals of maintaining aesthetic integrity and fostering economic stability within its districts. The program acts as a strategic tool to achieve these city-wide development and preservation objectives. The target beneficiaries of this program are businesses and mixed-use buildings over 30 years old located within the HD-1, HD-2, or HD-3 zoning districts. The impact goals are multifaceted, seeking to boost property development, strengthen both new and existing businesses, and facilitate the rehabilitation and modernization of downtown buildings. By supporting these specific entities, the program intends to create a ripple effect that benefits the entire community through improved infrastructure and a more vibrant commercial landscape. The program's priorities and focuses are clearly articulated: encouraging the preservation of historic structures, preventing general neighborhood deterioration, and promoting renovation and restoration. These priorities are addressed through the specific design of the grants, which require a 50-50 match, indicating a shared investment and commitment to the success of the projects. The emphasis on properties within designated historic and downtown zoning districts underscores the program's strategic focus on areas critical for community identity and economic activity. Expected outcomes include a visible improvement in the physical appearance of buildings within the targeted districts, increased property values, and a more robust local economy driven by strengthened businesses. Measurable results could include the number of facade renovations completed, the total amount of private investment leveraged by the matching grants, and potentially an increase in new business openings or retention rates within the program areas. While a formal "theory of change" is not explicitly stated for the City of Wentzville, the program implicitly operates on the principle that investing in the physical attractiveness and structural integrity of its commercial and historic properties will lead to enhanced community pride, increased economic activity, and sustained neighborhood vitality.

The AARP Foundation is offering a grant opportunity to organizations seeking to increase their impact by piloting a scaling strategy. This aligns with the AARP Foundation's mission to materially improve the circumstances of people aged 50 and over with incomes at or below 250% of the poverty line, lift their income above this threshold, or prevent them from falling below it. The Foundation also prioritizes programs that consult older adults in their development and implementation or create volunteer opportunities for them. This funding opportunity aims to support organizations in expanding their reach and depth to engage a larger audience, thereby addressing urgent problems faced by this demographic. The primary beneficiaries of this grant are individuals aged 50 and over who are living with low income. The impact goals are to improve the financial well-being of this population through direct services or non-direct services such as capacity building, systems change, or implementation. The Foundation is particularly interested in projects serving older adults in 22 specific U.S. states and territories that exhibit high levels of senior poverty, including Alabama, Arizona, and Puerto Rico, among others. Organizations from anywhere in the U.S. are eligible, but those serving populations disproportionately affected by systemic barriers, racial and ethnic disparities, and other harmful biases will be prioritized. The AARP Foundation's strategic priorities for this grant focus on scaling existing work to achieve greater impact. This can involve leveraging partnerships to increase program reach, using collaborative or coalition models to enhance organizational capacity, engaging new partners for policy implementation (excluding legislative advocacy), expanding public-private partnerships, applying effective systems-level approaches to new areas, or incorporating innovative strategies into existing programs. These diverse approaches reflect the Foundation's theory of change, which posits that by supporting organizations in scaling their effective programs, a broader positive impact on the economic security of older adults can be achieved. Expected outcomes and measurable results include increasing the number of 50+ individuals whose circumstances are materially improved, whose income is lifted above 250% of the poverty line, or who are prevented from falling below it. The grant aims to foster expanded reach and depth of programs, engaging larger audiences and demonstrating the effectiveness of various scaling strategies. The total program funding for this opportunity is up to $2 million, supporting projects for up to three years, indicating a commitment to sustained impact and the development of robust, scalable solutions to senior poverty.

The City of Provo and Utah Valley HOME Consortium are offering $1,759,085.00 in HOME Investment Partnership – American Rescue Plan (HOME-ARP) funding. This grant program is specifically designed for the acquisition and development of non-congregate shelters (NCS). While the specific foundation's mission alignment and strategic priorities are not detailed, the program's focus on providing safe housing aligns with broader community welfare and housing stability goals often supported by philanthropic foundations and governmental initiatives. The grant aims to address the critical need for secure, non-congregate housing for vulnerable populations. The primary target beneficiaries of this grant are individuals and families who are fleeing, or attempting to flee, domestic violence, dating violence, sexual assault, stalking, or human trafficking. This includes individuals as defined by the Department of Housing and Urban Development 24 CFR 5.2003. The impact goal is to provide immediate and safe shelter for these highly vulnerable individuals, offering them a secure environment as they escape dangerous situations. The emphasis on non-congregate shelters ensures a private and safer alternative to traditional shelters, which is particularly crucial for victims of violence. The priorities and focuses of this grant include the acquisition of land and construction of new non-congregate shelters, as well as the acquisition and/or rehabilitation of existing structures such as motels, hotels, or other facilities to be converted into NCS units. It is explicitly stated that no funds may be used for the operational costs of these shelters, emphasizing capital investment in creating new housing resources. This focus ensures that the grant directly contributes to increasing the physical infrastructure available to support the target population. Expected outcomes include an increase in the availability of safe, private, and secure non-congregate housing options within the Utah Valley HOME Consortium boundaries, which encompass Provo City and Utah County (excluding Eagle Mountain, Alpine, and Fairfield). Measurable results would be the number of new NCS units created or existing structures converted, and by extension, the number of individuals and families from the qualifying population who can be safely housed. The theory of change implicit in this grant is that by providing dedicated, non-congregate shelter, the program will empower victims to escape violence and trafficking, offering them a crucial first step towards long-term safety and recovery. Eligible applicants for this funding include nonprofit, governmental, and/or quasi-governmental agencies, housing authorities, and for-profit entities. These entities must serve the defined Qualifying Population within the specified geographic boundaries. The grant deadline is May 20, 2024. While the "Size of the Grant" is listed as "Not Available" in one section, the total funding available is clearly stated as $1,759,085.00, indicating the overall investment. The "Grant Duration" is also "Not Mentioned," suggesting that the focus is on the completion of the acquisition and development projects rather than ongoing operational support.

This grant provides financial support to not-for-profit organizations in Flagler County that create arts and cultural programs or events, fostering community enrichment and engagement.

The Advanced Industries Early-Stage Capital and Retention Grant aims to support Colorado-based advanced industries technology businesses in developing and commercializing new technologies that will be created or manufactured in the state. The grant addresses the market's underinvestment in early-stage technologies by offering financial support of up to $250,000, with the possibility of exceeding this amount for projects impacting multiple advanced industries. Eligible businesses must be involved in creating disruptive technology, be registered and in good standing with the Colorado Secretary of State, have a significant presence in Colorado, provide a 2-to-1 non-State funding match, and have limited prior financial support and revenues. Preference is given to applicants with ties to Colorado research institutions, entrepreneurship programs, and those recognized by investment groups for their commercial potential. Applications are accepted biannually Grant renewed every year. Grant Summer Annual deadline: July to September

This funding opportunity supports K-12 schools and organizations in Washington and Oregon to create hands-on environmental education projects that promote climate resilience and incorporate Indigenous Knowledge.

This funding opportunity seeks innovative research proposals from various entities, including businesses and universities, to develop groundbreaking technologies for national security, focusing on areas like novel materials, quantum computing, and artificial intelligence.

This grant provides funding to organizations developing a web-based mental health literacy curriculum and print guide to support individuals with intellectual and developmental disabilities and their families in understanding and managing co-occurring mental health challenges.

This competition provides funding and support for teams developing innovative high-temperature seismic sensors to improve geothermal energy monitoring and enhance the understanding of subsurface conditions.

Key aspects of the TSA: Multidisciplinary Collaboration: The success of the project should depend on the unique skills and perspectives of each partner. The application must clearly define the synergistic components that will facilitate and accelerate progress in melanoma in a way that could not be accomplished through independent efforts. The plans for interactions among all PIs and institutions involved must be clearly articulated. Collectively, the members of the research team should represent the appropriate diversity of expertise necessary for addressing the proposed research question. Participating institutions must be willing to resolve potential intellectual and material property issues and remove institutional barriers to achieving high levels of cooperation. The following components of the proposed multidisciplinary collaboration are encouraged but not required: It is strongly encouraged that the research team has a least one investigator, key personnel, or consultant who can provide input on the ultimate utility/applicability (short- or long-term) of the anticipated outcome(s) to the melanoma field and/or patient care. The inclusion of an early-career investigator is encouraged. An early-career investigator is defined as an independent, early-career researcher or physician-scientist within 7 years of receiving their first faculty appointment by the time of the full application deadline. Investigators in mentored positions, (e.g., postdoctoral fellows) are not eligible to be named as a PI on a TSA application. The inclusion of a military and/or U.S. Department of Veterans Affairs (VA) investigator is encouraged. A military or VA investigator is defined as an investigator who is active-duty, active reserve, active duty detailed to agencies outside of the Department of Defense (DOD), civilian DOD investigators, or an investigator at a VA research facility. If included as PI on the research team, the military/VA investigator should have a substantial role in the research and should not be included only for access to active-duty military and/or VA populations. Impact: The application must articulate the impact the proposed work, including basic research, will have on melanoma research and/or patient care. Outcomes from this award are expected to expedite the advancement of promising ideas toward clinical applications and/or improve the current state of the science/technology in the melanoma field. The proposed research must relate to at least one of the FY24 MRP Focus Areas in Section II.A.1. Preliminary Data Required: Applications must include preliminary data to support feasibility of the study. However, these data do not necessarily need to be derived from melanoma studies. Any unpublished, preliminary data presented should originate from the laboratory of at least one of the PIs or other member(s) of the research team.

This program provides funding to a variety of organizations to create experiential learning opportunities in emerging technology fields, helping individuals from diverse backgrounds gain skills and transition into STEM careers.

demonstrated significant potential to effect meaningful change in breast cancer. These individuals should be exceptionally talented scientists who have shown that they are the best and brightest in their field(s) through extraordinary creativity, vision, innovation, and productivity. They should have demonstrated experience in forming effective partnerships and collaborations and must exhibit strong potential for future leadership in breast cancer research.As the intent of the Era of Hope Scholar Award is to recognize creative and innovative individuals rather than projects, the central features of the award are the demonstrated ability of the individual named as the Principal Investigator (PI) in the application to go beyond conventional thinking in their field and the innovative contribution that the PI can make toward ending breast cancer. The application should articulate a vision that challenges current dogma and demonstrates an ability to look beyond tradition and convention.Experience in breast cancer research is not required; however, the application must focus on breast cancer, and the PI must commit a minimum of 25% level of time and effort during the period of performance to conduct breast cancer research under this award. Individuals from other disciplines who apply novel concepts to breast cancer are encouraged to submit.The PI is encouraged to assemble a research team that will provide the necessary expertise and collaborative efforts toward accomplishing the research goals. The PIs research team must include two or more breast cancer consumer advocates. As lay representatives, the consumer advocates must be individuals who have been diagnosed with breast cancer and are actively involved in a breast cancer advocacy organization. Their role should be independent of their employment, and they may not be employees of any organizations participating in the application. The consumer advocates should have a high level of knowledge of current breast cancer issues and the appropriate background and/or training in breast cancer research to contribute to the project. Their role should be focused on providing objective input throughout the research effort and its potential impact for individuals with, or at risk for, breast cancer.A congressionally mandated Metastatic Cancer Task Force was formed with the purpose of identifying ways to help accelerate clinical and translational research aimed at extending the lives of advanced state and recurrent patients. As a member of the Metastatic Cancer Task Force, CDMRP encourages applicants to review the recommendations (https://health.mil/Reference-Center/Congressional-Testimonies/2018/05/03/Metastatic-Cancer-Research) and submit research ideas to address these recommendations provided they are within the limitations of this funding opportunity and fit within the FY24 BCRP priorities.Innovative research involving nuclear medicine and related techniques to support early diagnosis, more effective treatment, and improved health outcomes of active-duty Service Members and their Families is encouraged. Such research could improve diagnostic and targeted treatment capabilities through noninvasive techniques and may drive the development of precision imaging and advanced targeted therapies.The proposed research must be relevant to active-duty Service Members, Veterans, military beneficiaries, and/or the American public. Collaborations between researchers at military or Veteran institutions and non-military institutions are strongly encouraged. These relationships can leverage knowledge, infrastructure, and access to unique clinical populations that the partners bring to the research effort, ultimately advancing cancer research that is of significance to the Warfighter, military Families, and the American public.Clinical trials are allowed. A clinical trial is defined in the Code of Federal Regulations, Title 45, Part 46.102 (45 CFR 46.102) as a research study in which one or more human subjects are prospectively assigned to one or more interventions (which may include a placebo or another control) to evaluate the effects of the interventions on biomedical or behavioral health-related outcomes.Studies that do not seek to measure safety, effectiveness, and/or efficacy outcome(s) of an intervention are not considered clinical trials.For the purposes of this funding opportunity, research that meets the definition of a clinical trial is distinct from clinical research. Clinical research encompasses research with human data, human specimens, and/or interaction with human subjects. Clinical research is observational in nature and includes: (1) Research conducted with human subjects and/or material of human origin such as data, specimens, and cognitive phenomena for which an investigator (or co-investigator) does not seek to assess the safety, effectiveness, and/or efficacy outcomes of an intervention. Research meeting this definition may include but is not limited to: (a) mechanisms of human disease, (b) diagnostic or detection studies (e.g., biomarker or imaging), (c) health disparity studies, and (d) development of new technologies.(2) Epidemiologic and behavioral studies that do not seek to assess the safety, effectiveness, and/or efficacy outcomes of an intervention.(3) Outcomes research and health services research that do not fit under the definition of clinical trial.Excluded from the definition of clinical research are in vitro studies that utilize human data or specimens that cannot be linked to a living individual and meet the requirements for exemption under 46.104(d)(4) of the Common Rule.The funding instrument for awards made under the program announcement will be grants (31 USC 6304).The anticipated direct costs budgeted for the entire period of performance for an FY24 Era of Hope Scholar Award should not exceed $3.5M. Refer to Section II.D.5, Funding Restrictions, for detailed funding information.Awards supported with FY24 funds will be made no later than September 30, 2025.The CDMRP expects to allot approximately $5.4M to fund approximately one Era of Hope Scholar Award application. Funding of applications received is contingent upon the availability of federal funds for this program, the number of applications received, the quality and merit of the applications as evaluated by peer and programmatic review, and the requirements of the government. Funds to be obligated on any award resulting from this funding opportunity will be available for use for a limited time period based on the fiscal year of the funds. It is anticipated that awards made from this FY24 funding opportunity will be funded with FY24 funds, which will expire for use on September 30, 2030.

This funding opportunity provides financial support for projects that develop and demonstrate innovative carbon capture technologies at existing industrial and power facilities, aiming to reduce greenhouse gas emissions and promote clean energy solutions.

This funding opportunity provides financial assistance to bioscience start-ups, early-stage businesses, and academic institutions in Connecticut to help accelerate the commercialization of innovative bioscience breakthroughs.

It is the policy of my Administration to advance womens health research, close health disparities, and ensure that the gains we make in research laboratories are translated into real-world clinical benefits for women. It is also the policy of my Administration to ensure that women have access to high-quality, evidence-based health care and to improve health outcomes for women across their lifespans and throughout the country. President Joseph R. Biden, Jr., Executive Order 14120 on Advancing Womens Health Research and Innovation, 18 March 2024.In support of the Presidents Executive Order to advance womens health research, the PRORP is releasing this WHRA funding opportunity. The intent of the FY24 PRORP WHRA is to support research focused on orthopaedic issues faced by women serving in military settings, such as infantry and other physically demanding roles, who have sustained orthopaedic injuries. The overall goal of the WHRA is to address factors that contribute to the health and retention of women in military service. Although use of military populations, datasets, or samples are not required, the application should demonstrate how the proposed research relates to issues faced by women serving in military settings. The proposed research project should also include a well-formulated, testable hypothesis based on sound scientific rationale and logical reasoning.Although the PRORP is interested in supporting military-focused research, research supported by the PRORP is expected to also apply to all individuals who have sustained a major orthopaedic injury.The PRORP encourages applications from a spectrum of research areas, including but not limited to translational and clinical research. The PRORP also welcomes qualitative research, population science, and health care services research specifically designed to understand the impact of orthopaedic injuries on female Service Members.With the initiation of the Arthritis Research Program, the FY24 PRORP may not fund arthritis research; however, research that addresses conditions or health abnormalities related to arthritis is permitted provided the proposed research addresses the PRORP WHRAs focus on orthopaedic injuries in women.A key feature of the PRORP WHRA is the relevance to female military and/or Veteran populations following orthopaedic injury. Inclusion of female military and/or Veteran populations is highly encouraged for applications proposing clinical research. Applicants proposing clinical studies in non-military and/or non-Veteran populations must justify the relevance of the proposed research to the military and/or Veteran communities. All applicants should clearly describe how their study design, including recruitment strategies and access to appropriate populations, as applicable, will enable them to meet this intent.Research involving human subjects, human datasets, and human anatomical substances is permitted; however, the WHRA may not be used to conduct clinical trials. Applicants seeking support for a clinical trial should consider the FY24 PRORP Clinical Trial Award (Funding Opportunity Number HT942524PRORPCTA).Clinical research encompasses research with human data, human specimens, and/or interaction with human subjects. Clinical research is observational in nature and includes:(1) Research conducted with human subjects and/or material of human origin such as data, specimens, and cognitive phenomena for which an investigator (or co-investigator) does not seek to assess the safety, effectiveness, and/or efficacy outcomes of an intervention. Research meeting this definition may include but is not limited to: (a) mechanisms of human disease, (b) diagnostic or detection studies (e.g., biomarker or imaging), (c) health disparity studies, and (d) development of new technologies.(2) Epidemiologic and behavioral studies that do not seek to assess the safety, effectiveness, and/or efficacy outcomes of an intervention.(3) Outcomes research and health services research that do not fit under the definition of clinical trial.Excluded from the definition of clinical research are in vitro studies that utilize human data or specimens that cannot be linked to a living individual and meet the requirements for exemption under 46.104(d)(4) of the Common Rule.A clinical trial is defined in the Code of Federal Regulations, Title 45, Part 46.102 (45 CFR 46.102) as a research study in which one or more human subjects are prospectively assigned to one or more interventions (which may include a placebo or another control) to evaluate the effects of the interventions on biomedical or behavioral health-related outcomes.Studies that do not seek to measure safety, effectiveness, and/or efficacy outcome(s) of an intervention are not considered clinical trials.Rigor of Experimental Design: All projects should adhere to a core set of standards for rigorous study design and reporting to maximize the reproducibility and translational potential of preclinical research. The standards are described in SC Landis et al., 2012, A call for transparent reporting to optimize the predictive value of preclinical research, Nature 490:187-191 (www.nature.com/nature/journal/v490/n7419/full/nature11556.html). While these standards are written for preclinical studies, the basic principles of randomization, blinding, sample-size estimation, and data handling derive from well-established best practices in clinical studies. Projects that include research on animal models are required to submit Attachment 7, Animal Research Plan, as part of the application package to describe how these standards will be addressed. Applicants should consult the ARRIVE guidelines 2.0 (Animal Research: Reporting In Vivo Experiments) to ensure relevant aspects of rigorous animal research are adequately planned for and, ultimately, reported. The ARRIVE guidelines 2.0 can be found at https://arriveguidelines.org/arrive-guidelines.Encouraged Department of Defense (DOD) and/or VA Collaboration: Applications from investigators within the military services and applications involving multidisciplinary collaborations among academia, industry, the military services, the VA, and other federal government agencies are encouraged. These relationships can leverage knowledge, infrastructure, and access to unique clinical populations that the collaborators bring to the research effort, ultimately advancing research that is of significance to Service Members, Veterans, and/or their Families. If the proposed research relies on access to unique resources or databases, the application must describe the access at the time of submission and include a plan for maintaining access as needed throughout the proposed research.The funding instrument for awards made under the program announcement will be grants (31 USC 6304).The anticipated total costs budgeted for the entire period of performance for an FY24 PRORP WHRA should not exceed $1.5M. Refer to Section II.D.5, Funding Restrictions, for detailed funding information.Awards supported with FY24 funds will be made no later than September 30, 2025.The CDMRP expects to allot approximately $3.0M to fund approximately two WHRA applications. Funding of applications received is contingent upon the availability of federal funds for this program, the number of applications received, the quality and merit of the applications as evaluated by peer and programmatic review, and the requirements of the government. Funds to be obligated on any award resulting from this funding opportunity will be available for use for a limited time period based on the fiscal year of the funds. It is anticipated that awards made from this FY24 funding opportunity will be funded with FY24 funds, which will expire for use on September 30, 2030.

This funding opportunity supports nonprofit organizations, municipalities, Tribal Nations, and individual artists in Tompkins County to create professional public arts events that engage diverse communities and address local cultural needs.

This grant provides funding to researchers and organizations developing innovative medical solutions to improve the treatment and outcomes of burn injuries for military personnel in challenging environments.

This grant caters to unique and innovative projects that do not fit the conventional frameworks of the other sub-grants but still demonstrate significant economic development merit. Eligible projects may include feasibility studies, engineered drawings, architecture plans, and planning studies. These projects should aim to significantly impact the economic landscape of Goshen County. Deadlines: Applications due first Friday of November, February, May, August